These medications, produced are GLP-1 receptor agonists and contain the same active ingredient, semaglutide
Hypoglycaemia: Mainly if combined with insulin or sulphonylurea
Dose changes can affect nausea, vomiting, dehydration risk, glucose control, and other medicines
It is important to note that while the pharmacies we work with are FDA-registered and inspected, compounded medications themselves are not FDA-approved
Wegovy semaglutide tablets were approved by the MHRA on that date, making the UK the first country in Europe to license an oral GLP-1 for weight management
The refrigerated shelf life of tirzepatide follows similar patterns, and the degradation mechanisms are comparable though not identical